Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Alan Dal Pra

Dr. Alan Dal Pra

Radiation Oncologist

Dr. Alan Dal Pra is a highly acclaimed radiation oncologist who treats patients with pleural mesothelioma at the University of Miami Sylvester Comprehensive Cancer Center.

Get in touch
Jump to a Topic:

About Alan Dal Pra

Accolades
  • Board Certified icon

    Board Certified in Radiation Oncology

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Board Certified icon

    Board Certified in Thoracic Surgery

  • Works for Specialty Center icon

    Works for Specialty Center

Get to Know Dr. Alan Dal Pra

Dr. Alan Dal Pra is the medical director of radiation oncology and a key figure in the multidisciplinary treatment of pleural mesothelioma at the Sylvester Comprehensive Cancer Center in Miami.

He was one of the first physicians to treat mesothelioma patients with Tumor Treating Fields, a novel cancer therapy that limits tumor growth with alternating electrical fields.

Tumor Treating Fields was approved by the U.S. Food and Drug Administration for use with mesothelioma in 2019, the first new therapy approval since 2004.

As part of treatment for thoracic cancers, Dal Pra also has embraced the addition of immunotherapy in combination with standard of care. In the department of radiation oncology, he serves as associate director of clinical research.

Dal Pra also treats prostate, bladder, kidney and adrenal cancers. Through the COVID-19 pandemic, he played a major role in virtual multidisciplinary clinics that addressed several cancers, including mesothelioma.

Specialties of Dr. Alan Dal Pra

  • Radiation oncology
  • Tumor Treating Fields
  • Genitourinary oncology
  • Thoracic tumors
  • Clinical and translational research
  • Mesothelioma cancer
  • Lung cancer

Dr. Alan Dal Pra’s Experience and Medical Education

  • Sylvester Comprehensive Cancer Center
  • Inselspital, University Hospital, Bern, Switzerland
  • Princess Margaret Cancer Centre, University of Toronto (Fellowship)
  • McGill University, Montreal (Fellowship)
  • Federal University of Rio Grande do Sul, Brazil (M.D.)

Awards and Other Recognitions

  • Canadian Association of Radiation Oncology Reviewers’ Choice Award
  • ESMO Preceptorship on Prostate Cancer
  • Best Scientific Papers, Brazilian Meeting of Radiation Oncology
  • AACR Aspen Workshop: Molecular Biology
  • Canadian Urology Oncology Group and Amgen Research Award
  • 1st Sao Paulo School of Translational Science

Mesothelioma Clinical Trials Under Dr. Alan Dal Pra

  • A phase III clinical trial measuring the efficacy of chemotherapy and radiation therapy work with or without atezolizumab in treating patients with localized bladder cancer.
  • A phase II clinical trial studying the efficacy of salvage radiotherapy plus metformin in comparison to the radiotherapy without metformin after prostate failure.

See More Top Mesothelioma Doctors

Publications of Dr. Alan Dal Pra

  • Panje, C. et al. (2019, October 16). Radiotherapy for Pelvic Nodal Recurrences After Radical Prostatectomy: Patient Selection in Clinical Practice. Radiation Oncology.
  • Malla, B., Aebersold, D.M. & Dal Pra, A. (2018, August 13). Protocol for Serum Exosomal miRNAs Analysis in Prostate Cancer Patients Treated with Radiotherapy. Journal of Translational Medicine.
  • Malla, B. et al. (2017, August 1). Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation Therapy. International Journal of Radiation Oncology.
  • Fraser, M. et al. (2017, January 19). Genomic Hallmarks of Localized, Non-Indolent Prostate Cancer. Nature.

Disclaimer: Dr. Alan Dal Pra has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Asbestos.com Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Fran Mannino, editor for The Mesothelioma Center
Edited by

3 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Sylvester Comprehensive Cancer Center. (n.d.). Alan Dal Pra, M.D.
    Retrieved from: http://radonc.med.miami.edu/about-us/our-faculty/alan-libardi-dal-pra-m.d
  2. ClinicalTrials.gov. (2020, June 16). Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer.
    Retrieved from: https://clinicaltrials.gov/ct2/show/NCT03775265
  3. ClinicalTrials.gov. (2020, May 12). SAKK 08/15 — PROMET — Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy. Retrieved from: https://clinicaltrials.gov/ct2/show/NCT02945813
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 28, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now